| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―05 |
Modelling the impact of vaccination-dependent contact rates on disease transmission: Applications to COVID-19 |
Izel Avkan, Ewan Colman |
| 2 |
[GO] |
2026―Mar―28 |
COVID-19 Forecasting from U.S. Wastewater Surveillance Data: A Retrospective Multi-Model Study (2022-2024) |
Faharudeen Alhassan, Hamed Karami, Amanda Bleichrodt, James M. Hyman, Isaac C H Fung, Ruiyan Luo, Gerardo Chowell |
| 3 |
[GO] |
2026―Mar―05 |
Editorial: Improving pandemic and epidemic responses - novel methods and lessons learned from previous infectious disease outbreaks |
Ben Swallow, Jasmina Panovska-Griffiths |
| 4 |
[GO] |
2025―Dec―06 |
Antibody escape of SARS-CoV-2 variants of concern on receptor-binding domain: A computational approach |
Dac-Nhan Nguyen, Quoc-Thai Nguyen, My Thoai Dang, Phuong-Uyen Tran-Thi, Viet-Hung Tran, Minh-Tri Le, et al. (+4) Lam-Truong Tuong, Van-Thanh Tran, Phuong Nguyen Hoai Huynh, Khac-Minh Thai |
| 5 |
[GO] |
2025―Oct―07 |
Assessing respiratory virus co-infections using an identifiable model: the case of influenza and SARS-CoV-2 in Italy |
Yafei Zhao, Sabrina Averga, Bruno Buonomo, Jie Lou |
| 6 |
[GO] |
2025―Aug―24 |
Stochastic modelling of early-stage COVID-19 epidemic dynamics in rural communities in the United States |
Punya Alahakoon, Peter G. Taylor, James M. Mccaw |
| 7 |
[GO] |
2025―Aug―10 |
Preventing SARS-CoV-2 superspreading events with antiviral intranasal sprays |
George Booth, Christoforos Hadjichrysanthou, Keira L. Rice, Jacopo Frallicciardi, Zoltán Magyarics, Frank de Wolf, et al. (+3) Jaap Goudsmit, Anna L. Beukenhorst, Roy Anderson |
| 8 |
[GO] |
2025―Jul―27 |
Time-delay enhanced SIR model for COVID-19 waves in Mexico: Parameter estimation using evolutionary algorithms |
Anahí Flores-Pérez, Marcos A. González-Olvera, Gustavo Chávez-Peña, Ana G. Gallardo-Hernández, Lizeth Torres |
| 9 |
[GO] |
2025―Jun―07 |
Estimating the Contribution of Age-Structure to the COVID-19 Epidemic in England |
Robert Hinch, Jasmina Panovska-Griffiths, Christophe Fraser |
| 10 |
[GO] |
2025―May―24 |
Contact Data and SARS-CoV-2: retrospective analysis of the estimated impact of the first UK Lockdown |
Joel Kandiah, Edwin Van Leeuwen, Paul J. Birrell, Daniela De Angelis |
| 11 |
[GO] |
2025―May―09 |
Network modeling of the different SARS-CoV-2 spike protein infection points within the human hematopoietic network |
Marni E. Cueno, Noa Shintaku, Noe Hayasaki, Yuna Migita, Kenichi Imai |
| 12 |
[GO] |
2025―Apr―28 |
Probability of Extinction and Peak Time for Multi-Type Epidemics with Application to COVID-19 Variants of Concern |
Jacob Curran-Sebastian, Louise Dyson, Edward M. Hill, Ian Hall, Lorenzo Pellis, Thomas House |
| 13 |
[GO] |
2025―Feb―16 |
Optimal social distancing in pandemic preparedness and lessons from COVID-19: Intervention intensity and infective travelers |
Alberto Landi, Giulio Pisaneschi, Marco Laurino, Piero Manfredi |
| 14 |
[GO] |
2024―Nov―23 |
An analytical, numerical and experimental study of in-vitro SARS-CoV-2 evolution in Vero B4 cells. |
Matthew Nicol, Julian D.J. Sng, Yanshan Zhu, Sissy Therese Sonnleitner, Kirsty R. Short, Meagan Carney |
| 15 |
[GO] |
2024―Oct―02 |
Exploring the treatment of SARS-CoV-2 with modified vesicular stomatitis virus |
Nishnath Polavarapu, Madison Doty, Hana M. Dobrovolny |
| 16 |
[GO] |
2024―Jul―05 |
Multiple pandemic waves vs multi-period/multi-phasic epidemics: Global shape of the COVID-19 pandemic |
Alberto d’Onofrio, Mimmo Iannelli, Gabriela Marinoschi, Piero Manfredi |
| 17 |
[GO] |
2024―Mar―15 |
Human movement avoidance decisions during Coronavirus disease 2019 in Japan |
Ryosuke Omori, Koichi Ito, Shunsuke Kanemitsu, Ryusuke Kimura, Yoh Iwasa |
| 18 |
[GO] |
2024―Mar―05 |
Decomposing mechanisms of COVID-19 mortality in empirical datasets: A modeling study |
Tong Zhang, Jiaying Qiao, Katsuma Hayashi, Hiroshi Nishiura |
| 19 |
[GO] |
2024―Jan―11 |
Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium |
Leonardo Angeli, Constantino Pereira Caetano, Nicolas Franco, Steven Abrams, Pietro Coletti, Inneke Van Nieuwenhuyse, et al. (+2) Sorin Pop, Niel Hens |
| 20 |
[GO] |
2023―Nov―15 |
Modeling long COVID dynamics: Impact of underlying health conditions |
Jie Bai, Jin Wang |
| 21 |
[GO] |
2023―Sep―19 |
Data-driven models for the risk of infection and hospitalization during a pandemic: Case study on COVID-19 in Nepal |
Khagendra Adhikari, Ramesh Gautam, Anjana Pokharel, Kedar Nath Uprety, Naveen K. Vaidya |
| 22 |
[GO] |
2023―Aug―26 |
Modeling the XBB strain of SARS-CoV-2: Competition between variants and impact of reinfection |
Ziqiang Cheng, Yinglei Lai, Kui Jin, Mengping Zhang, Jin Wang |
| 23 |
[GO] |
2023―Aug―18 |
A model-based strategy for the COVID-19 vaccine roll-out in the Philippines |
Rey Audie S. Escosio, Olive R. Cawiding, Bryan S. Hernandez, Renier G. Mendoza, Victoria May P. Mendoza, Rhudaina Z. Mohammad, et al. (+6) Carlene P.C. Pilar-Arceo, Pamela Kim N. Salonga, Fatima Lois E. Suarez, Polly W. Sy, Thomas Herald M. Vergara, Aurelio A. de los Reyes V |
| 24 |
[GO] |
2023―Jul―05 |
Workplace absenteeism due to COVID-19 and influenza across Canada: A mathematical model |
W.S. Avusuglo, Rahele Mosleh, Tedi Ramaj, Ao Li, Sileshi Sintayehu Sharbayta, Abdoul Aziz Fall, et al. (+6) Srijana Ghimire, Fenglin Shi, Jason K.H. Lee, Edward Thommes, Thomas Shin, Jianhong Wu |
| 25 |
[GO] |
2023―Jul―01 |
Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors |
Pranesh Padmanabhan, Narendra M. Dixit |
| 26 |
[GO] |
2023―May―18 |
Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants |
Shuanglin Jing, Russell Milne, Hao Wang, Ling Xue |
| 27 |
[GO] |
2023―Mar―23 |
Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 hours post infection |
Jason Pearson, Timothy Wessler, Alex Chen, Richard C. Boucher, Ronit Freeman, Samuel K. Lai, et al. (+2) Raymond Pickles, M. Gregory Forest |
| 28 |
[GO] |
2023―Mar―20 |
A multi-strain model with asymptomatic transmission: Application to COVID-19 in the US |
Shasha Gao, Mingwang Shen, Xueying Wang, Jin Wang, Maia Martcheva, Libin Rong |
| 29 |
[GO] |
2023―Mar―08 |
Simplified within-host and Dose-response Models of SARS-CoV-2 |
Jingsi Xu, Jonathan Carruthers, Thomas Finnie, Ian Hall |
| 30 |
[GO] |
2023―Mar―07 |
Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile |
Chapin S. Korosec, Matthew I. Betti, David W. Dick, Hsu Kiang Ooi, Iain R. Moyles, Lindi M. Wahl, Jane M. Heffernan |
| 31 |
[GO] |
2023―Jan―07 |
Projecting COVID-19 cases and hospital burden in Ohio |
Wasiur R. KhudaBukhsh, Caleb Deen Bastian, Matthew Wascher, Colin Klaus, Saumya Yashmohini Sahai, Mark Weir, et al. (+4) Eben Kenah, Elisabeth Root, Joseph H. Tien, Grzegorz Rempała |
| 32 |
[GO] |
2022―Dec―28 |
Pandemic modelling for regions implementing an elimination strategy |
Amy Hurford, Maria M. Martignoni, J.C. Loredo-Osti, Francis Anokye, Julien Arino, Bilal Saleh Husain, et al. (+2) Brian Gaas, James Watmough |
| 33 |
[GO] |
2022―Dec―28 |
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors |
Daiki Tatematsu, Marwa Akao, Hyeongki Park, Shingo Iwami, Keisuke Ejima, Shoya Iwanami |
| 34 |
[GO] |
2022―Dec―14 |
Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination |
Misaki Sasanami, Marie Fujimoto, Taishi Kayano, Katsuma Hayashi, Hiroshi Nishiura |
| 35 |
[GO] |
2022―Dec―07 |
Adaptive behaviors and vaccination on curbing COVID-19 transmission: Modeling simulations in eight countries |
Zhaowan Li, Jianguo Zhao, Yuhao Zhou, Lina Tian, Qihuai Liu, Huaiping Zhu, Guanghu Zhu |
| 36 |
[GO] |
2022―Dec―05 |
Structural patterns of SARS-CoV-2 variants of concern (alpha, beta, gamma, delta) spike protein are influenced by variant-specific amino acid mutations: A computational study with implications on viral evolution |
Marni E. Cueno, Kanta Wada, Arisa Tsuji, Kouta Ishikawa, Kenichi Imai |
| 37 |
[GO] |
2022―Nov―24 |
COVID-19 endgame: From pandemic to endemic? Vaccination, reopening and evolution in low- and high-vaccinated populations |
Elisha B. Are, Yexuan Song, Jessica E. Stockdale, Paul Tupper, Caroline Colijn |
| 38 |
[GO] |
2022―Nov―14 |
Exploring the role of superspreading events in SARS-CoV-2 outbreaks |
Jordan Bramble, Alexander Fulk, Raul Saenz, Folashade B. Agusto |
| 39 |
[GO] |
2022―Nov―06 |
Uncertainty and error in SARS-CoV-2 epidemiological parameters inferred from population-level epidemic models |
Dominic G. Whittaker, Alejandra D. Herrera-Reyes, Maurice Hendrix, Markus R. Owen, Leah R. Band, Gary R. Mirams, et al. (+2) Kirsty J. Bolton, Simon P. Preston |
| 40 |
[GO] |
2022―Nov―05 |
Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK |
Ewan Colman, Gavrila A. Puspitarani, Jessica Enright, Rowland R. Kao |
| 41 |
[GO] |
2022―Nov―02 |
Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential |
Carl A. Whitfield, Ian Hall |
| 42 |
[GO] |
2022―Oct―30 |
Getting the most out of maths: How to coordinate mathematical modelling research to support a pandemic, lessons learnt from three initiatives that were part of the COVID-19 response in the UK |
Ciara E. Dangerfield, I. David Abrahams, Chris Budd, Matt Butchers, Michael E Cates, Alan R. Champneys, et al. (+20) Christine S.M. Currie, Jessica Enright, Julia R Gog, Alain Goriely, T. Déirdre Hollingsworth, Rebecca B. Hoyle, INI Professional Services, Valerie Isham, Joanna Jordan, Maha Kaouri, Kostas Kavoussanakis, Jane Leeks, Philip K Maini, Christie Marr, Clare Merritt, Denis Mollison, Surajit Ray, Robin N. Thompson, Alexandra Wakefield, Dawn Wasley |
| 43 |
[GO] |
2022―Oct―30 |
Exploring COVID-19 transmission patterns and key factors during epidemics caused by three major strains in Asia |
Han Tu, Xia Wang, Sanyi Tang |
| 44 |
[GO] |
2022―Oct―26 |
Modified susceptible-exposed-infectious-recovered model for assessing the effectiveness of non-pharmaceutical interventions during the COVID-19 pandemic in Seoul |
Seungpil Jung, Jong-Hoon Kim, Seung-Sik Hwang, Junyoung Choi, Woojoo Lee |
| 45 |
[GO] |
2022―Oct―26 |
Modelling the epidemiological implications for SARS-CoV-2 of Christmas household bubbles in England |
Edward M. Hill |
| 46 |
[GO] |
2022―Oct―25 |
Antibody protection from SARS-CoV-2 respiratory tract exposure and infection |
Alex Chen, Timothy Wessler, M. Gregory Forest |
| 47 |
[GO] |
2022―Oct―15 |
Patterns of reported infection and reinfection of SARS-CoV-2 in England |
Matt J. Keeling |
| 48 |
[GO] |
2022―Oct―05 |
Analysis of Serological Surveys of Antibodies to SARS-CoV-2 in the United States to Estimate Parameters Needed for Transmission Modeling and to Evaluate and Improve the Accuracy of Predictions |
John W Glasser, Zhilan Feng, MyVan Vo, Jefferson N Jones, Kristie E.N. Clarke |
| 49 |
[GO] |
2022―Oct―05 |
A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate response |
Andreas C. Aristotelous, Alex Chen, M. Gregory Forest |
| 50 |
[GO] |
2022―Oct―04 |
A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing antibodies following COVID-19 vaccination |
Lisette de Pillis, Rebecca Caffrey, Ge Chen, Mark D. Dela, Leif Eldevik, Joseph McConnell, et al. (+2) Shahrokh Shabahang, Stephen A. Varvel |
| 51 |
[GO] |
2022―Sep―20 |
Spatiotemporal pattern recognition and dynamical analysis of COVID-19 in Shanghai, China |
Haonan Zhong, Kaifa Wang, Wendi Wang |
| 52 |
[GO] |
2022―Aug―28 |
The heterogeneous mixing model of COVID-19 with interventions |
Moran Duan, Zhen Jin |
| 53 |
[GO] |
2022―May―02 |
A multi-strain epidemic model for COVID-19 with infected and asymptomatic cases: application to French data |
Mathilde Massard, Raluca Eftimie, Antoine Perasso, Bruno Saussereau |
| 54 |
[GO] |
2022―Apr―30 |
A quantitative method to project the probability of the end of an epidemic: Application to the COVID-19 outbreak in Wuhan, 2020 |
Baoyin Yuan, Rui Liu, Sanyi Tang |
| 55 |
[GO] |
2022―Mar―21 |
The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: A conceptual model for COVID-19 |
Shi Zhao, Kai Wang, Marc K.C. Chong, Salihu S Musa, Mu He, Lefei Han, et al. (+2) Daihai He, Maggie H. Wang |
| 56 |
[GO] |
2022―Feb―18 |
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold |
M. Gabriela M. Gomes, Marcelo U. Ferreira, Rodrigo M. Corder, Jessica G. King, Caetano Souto-Maior, Carlos Penha-Gonçalves, et al. (+4) Guilherme Gonçalves, Maria Chikina, Wesley Pegden, Ricardo Aguas |
| 57 |
[GO] |
2021―Dec―13 |
Estimating local outbreak risks and the effects of non-pharmaceutical interventions in age-structured populations: SARS-CoV-2 as a case study |
Francesca A. Lovell-Read, Silvia Shen, Robin N. Thompson |
| 58 |
[GO] |
2021―Dec―08 |
A behavioural modelling approach to assess the impact of COVID-19 vaccine hesitancy |
Bruno Buonomo, Rossella Della Marca, Alberto d’Onofrio, Maria Groppi |
| 59 |
[GO] |
2021―Sep―27 |
Differential impacts of contact tracing and lockdowns on outbreak size in COVID-19 model applied to China |
Cameron J. Browne, Hayriye Gulbudak, Joshua C. Macdonald |
| 60 |
[GO] |
2021―Sep―09 |
Network Models to Evaluate Vaccine Strategies towards Herd Immunity in COVID-19 |
Josephine N.A. Tetteh, Van Kinh Nguyen, Esteban A. Hernandez-Vargas |
| 61 |
[GO] |
2021―Sep―06 |
Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells |
Veronika Bernhauerová, Bartek Lisowski, Veronica V. Rezelj, Marco Vignuzzi |
| 62 |
[GO] |
2021―Aug―31 |
Inverted repeats in coronavirus SARS-CoV-2 genome manifest the evolution events |
Changchuan Yin, Stephen S.-T. Yau |
| 63 |
[GO] |
2021―Aug―21 |
Modelling COVID-19 dynamics and potential for herd immunity by vaccination in Austria, Luxembourg and Sweden |
Francoise Kemp, Daniele Proverbio, Atte Aalto, Laurent Mombaerts, Aymeric Fouquier d’Herouel, Andreas Husch, et al. (+4) Christophe Ley, Jorge Goncalves, Alexander Skupin, Stefano Magni |
| 64 |
[GO] |
2021―Aug―11 |
Shrinkage in serial intervals across transmission generations of COVID-19 |
Shi Zhao, Yu Zhao, Biao Tang, Daozhou Gao, Zihao Guo, Marc K.C. Chong, et al. (+5) Salihu S Musa, Yongli Cai, Weiming Wang, Daihai He, Maggie H Wang |
| 65 |
[GO] |
2021―May―24 |
Application of a novel mathematical model to identify intermediate hosts of SARS-CoV-2 |
Katherine Royce |
| 66 |
[GO] |
2021―Apr―21 |
Impact of intervention on the spread of COVID-19 in India: A model based study |
Abhishek Senapati, Sourav Rana, Tamalendu Das, Joydev Chattopadhyay |
| 67 |
[GO] |
2021―Apr―13 |
Modelling strategies to organize healthcare workforce during pandemics: application to COVID-19 |
Daniel Sánchez-Taltavull, Violeta Castelo-Szekely, Daniel Candinas, Edgar Roldán, Guido Beldi |
| 68 |
[GO] |
2021―Mar―30 |
Joint impacts of media, vaccination and treatment on an epidemic Filippov model with application to COVID-19 |
Jiawei Deng, Sanyi Tang, Hongying Shu |
| 69 |
[GO] |
2021―Mar―24 |
Transmission Dynamics of COVID-19 in Nepal: Mathematical Model Uncovering Effective Controls |
Khagendra Adhikari, Ramesh Gautam, Anjana Pokharel, Kedar Nath Uprety, Naveen K. Vaidya |
| 70 |
[GO] |
2021―Mar―23 |
Human choice to self-isolate in the face of the COVID-19 pandemic: a game dynamic modelling approach |
Calistus N. Ngonghala, Palak Goel, Daniel Kutor, Samit Bhattacharyya |
| 71 |
[GO] |
2021―Feb―15 |
Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination |
Ruian Ke, Ethan Romero-Severson, Steven Sanche, Nick Hengartner |
| 72 |
[GO] |
2021―Jan―26 |
Latent periodicity-2 in coronavirus SARS-CoV-2 genome: evolutionary implications |
Changchuan Yin |
| 73 |
[GO] |
2021―Jan―13 |
Effects of latency and age structure on the dynamics and containment of COVID-19 |
K.B. Blyuss, Y.N. Kyrychko |
| 74 |
[GO] |
2020―Dec―30 |
Optimal Strategies for Social Distancing and Testing to Control COVID-19 |
Wongyeong Choi, Eunha Shim |
| 75 |
[GO] |
2020―Dec―30 |
A simple correction for COVID-19 sampling bias |
Daniel Andrés Díaz-Pachón, J. Sunil Rao |
| 76 |
[GO] |
2020―Nov―24 |
A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing |
Jana L. Gevertz, James M. Greene, Cynthia H. Sanchez-Tapia, Eduardo D. Sontag |
| 77 |
[GO] |
2020―Nov―10 |
A model of COVID-19 propagation based on a gamma subordinated negative binomial branching process |
Jérôme Levesque, David W. Maybury, R.H.A. David Shaw |
| 78 |
[GO] |
2020―Sep―25 |
Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom |
Z. Liu, P. Magal, G. Webb |
| 79 |
[GO] |
2020―Aug―29 |
When to lift the lockdown in Hubei province during COVID-19 epidemic? an insight from a patch model and multiple source data |
Xiaodan Sun, Yanni Xiao, Xiangting Ji |
| 80 |
[GO] |
2020―Aug―29 |
Predicting the second wave of COVID-19 in Washtenaw County, MI |
Marissa Renardy, Denise Kirschner |
| 81 |
[GO] |
2020―Aug―16 |
Rapid, large-scale, and effective detection of COVID-19 via non-adaptive testing |
Matthias Täufer |
| 82 |
[GO] |
2020―Jul―29 |
Design of an engineered ACE2 as a novel therapeutics against COVID-19 |
Zahra Payandeh, Mohammad Reza Rahbar, Abolfazl Jahangiri, Zahra Sadat Hashemi, Alireza Zakeri, Moslem Jafarisani, et al. (+2) Mohammad Javad Rasaee, Saeed Khalili |
| 83 |
[GO] |
2020―Jun―25 |
Impact of media reports on the early spread of COVID-19 epidemic |
Qinling Yan, Yingling Tang, Dingding Yan, Jiaying Wang, Linqian Yang, Xinpei Yang, Sanyi Tang |